Annual report
2934.TEDINET S100P44C
Period2021-06-01 → 2022-05-31
Filed2022-08-31
StandardJapan GAAP
ConsolidatedYes
Data checks17 of 17 passed
Key figures · 98
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.9bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales |
| Operating income | ¥732m | 2021-06-01 → 2022-05-31 | Cons. | Operating income |
| Ordinary income | ¥713m | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥702m | 2021-06-01 → 2022-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥401m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥400m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss |
| Total assets | ¥6.1bn | at 2022-05-31 | Cons. | Assets |
| Total liabilities | ¥1.9bn | at 2022-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥4.2bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2021-05-31 | Cons. | Net assets |
| Cash and deposits | ¥3.0bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.0bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2021-05-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥367m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥860m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥2.6bn | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥90.64 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥86.68 | 2021-06-01 → 2022-05-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥907.43 | at 2022-05-31 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 68.2% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 9.7% | 2021-06-01 → 2022-05-31 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 278 | at 2022-05-31 | Cons. | Number of employees |
| Revenue | ¥9.3bn | 2021-06-01 → 2022-05-31 | Standalone | Net sales |
| Revenue | ¥8.5bn | 2020-06-01 → 2021-05-31 | Standalone | Net sales |
| Revenue | ¥7.1bn | 2019-06-01 → 2020-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.1bn | 2018-06-01 → 2019-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.2bn | 2017-06-01 → 2018-05-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥751m | 2021-06-01 → 2022-05-31 | Standalone | Operating income |
| Operating income | ¥672m | 2020-06-01 → 2021-05-31 | Standalone | Operating income |
| Ordinary income | ¥724m | 2021-06-01 → 2022-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥679m | 2020-06-01 → 2021-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥174m | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥367m | 2018-06-01 → 2019-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥589m | 2017-06-01 → 2018-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥723m | 2021-06-01 → 2022-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥679m | 2020-06-01 → 2021-05-31 | Standalone | Income before income taxes |
| Net income | ¥450m | 2021-06-01 → 2022-05-31 | Standalone | Profit loss |
| Net income | ¥425m | 2020-06-01 → 2021-05-31 | Standalone | Profit loss |
| Net income | ¥96m | 2019-06-01 → 2020-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥6m | 2018-06-01 → 2019-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥399m | 2017-06-01 → 2018-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥5.3bn | at 2022-05-31 | Standalone | Assets |
| Total assets | ¥2.6bn | at 2021-05-31 | Standalone | Assets |
| Total assets | ¥2.0bn | at 2020-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.9bn | at 2019-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.5bn | at 2018-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.1bn | at 2022-05-31 | Standalone | Liabilities |
| Total liabilities | ¥1.3bn | at 2021-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥4.2bn | at 2022-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2021-05-31 | Standalone | Net assets |
| Net assets / equity | ¥843m | at 2020-05-31d | Standalone | Net assets |
| Net assets / equity | ¥746m | at 2019-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥739m | at 2018-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2022-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2021-05-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥1.6bn | at 2021-05-31 | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥902m | at 2020-05-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥948m | at 2019-05-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥831m | 2020-06-01 → 2021-05-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥218m | 2019-06-01 → 2020-05-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥14m | 2018-06-01 → 2019-05-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥8m | 2020-06-01 → 2021-05-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥165m | 2019-06-01 → 2020-05-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥63m | 2018-06-01 → 2019-05-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥94m | 2020-06-01 → 2021-05-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥99m | 2019-06-01 → 2020-05-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥130m | 2018-06-01 → 2019-05-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥101.91 | 2021-06-01 → 2022-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥110.75 | 2020-06-01 → 2021-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.12 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.6 | 2018-06-01 → 2019-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥207.98 | 2017-06-01 → 2018-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥97.45 | 2021-06-01 → 2022-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥918.35 | at 2022-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥329.99 | at 2021-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥219.25 | at 2020-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥194.13 | at 2019-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥385.07 | at 2018-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 79.0% | at 2022-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.8% | at 2021-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.5% | at 2020-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.0% | at 2019-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.6% | at 2018-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.5% | 2021-06-01 → 2022-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 40.3% | 2020-06-01 → 2021-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.2% | 2019-06-01 → 2020-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.8% | 2018-06-01 → 2019-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 74.0% | 2017-06-01 → 2018-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 4,757,616 | at 2022-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,918,500 | at 2021-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,918,500 | at 2020-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,918,500 | at 2019-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,918,500 | at 2018-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 54 | at 2022-05-31 | Standalone | Number of employees |
| Employees | 46 | at 2021-05-31 | Standalone | Number of employees |
| Employees | 47 | at 2020-05-31d | Standalone | Number of employees |
| Employees | 42 | at 2019-05-31d | Standalone | Number of employees |
| Employees | 37 | at 2018-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2021-06-01 → 2022-05-31 | ¥5m |
| Reconciling Itemsreconciling | depreciation | 2021-06-01 → 2022-05-31 | ¥5m |
| Reconciling Itemsreconciling | revenue | 2021-06-01 → 2022-05-31 | −¥54m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-06-01 → 2022-05-31 | −¥54m |
| Reconciling Itemsreconciling | segment assets | at 2022-05-31 | ¥2.7bn |
| Reconciling Itemsreconciling | segment profit | 2021-06-01 → 2022-05-31 | −¥425m |
| Healthcare Marketing Businessreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥362m |
| Healthcare Marketing Businessreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥2m |
| Healthcare Marketing Businessreportable segment | employees | at 2022-05-31 | 99 pure |
| Healthcare Marketing Businessreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥3.9bn |
| Healthcare Marketing Businessreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥3.8bn |
| Healthcare Marketing Businessreportable segment | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥54m |
| Healthcare Marketing Businessreportable segment | segment assets | at 2022-05-31 | ¥1.3bn |
| Healthcare Marketing Businessreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥37m |
| Healthcare Sales Businessreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥703,000 |
| Healthcare Sales Businessreportable segment | employees | at 2022-05-31 | 23 pure |
| Healthcare Sales Businessreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥3.0bn |
| Healthcare Sales Businessreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥3.0bn |
| Healthcare Sales Businessreportable segment | segment assets | at 2022-05-31 | ¥251m |
| Healthcare Sales Businessreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥779m |
| Medical Care Sales Businessreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥544m |
| Medical Care Sales Businessreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥3m |
| Medical Care Sales Businessreportable segment | employees | at 2022-05-31 | 142 pure |
| Medical Care Sales Businessreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥5.0bn |
| Medical Care Sales Businessreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥5.0bn |
| Medical Care Sales Businessreportable segment | segment assets | at 2022-05-31 | ¥1.8bn |
| Medical Care Sales Businessreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥340m |
| —segment total | employees | at 2022-05-31 | 278 pure |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-06-01 → 2022-05-31 | ¥907m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-06-01 → 2022-05-31 | ¥5m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2022-05-31 | ¥11.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2022-05-31 | ¥11.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥54m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-05-31 | ¥3.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2022-05-31 | ¥1.2bn |
| Healthcare Marketing Businessreportable segment | employees | at 2022-05-31 | 10 pure |
| Healthcare Sales Businessreportable segment | employees | at 2022-05-31 | 23 pure |
| Medical Care Sales Businessreportable segment | employees | at 2022-05-31 | 10 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,094
| Item | Context | Value | Unit |
|---|---|---|---|
| Amortization of long term prepaid expenses ope cf | CurrentYearDuration | 2238000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYearDuration | 1850000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYearDuration | -281000 | JPY |
| Interest and dividends income ope cf | CurrentYearDuration | -114000 | JPY |
| Interest expenses ope cf | CurrentYearDuration | 1449000 | JPY |
| Loss on retirement of noncurrent assets ope cf | CurrentYearDuration | 1448000 | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYearDuration | 9854000 | JPY |
| Stock issuance cost ope cf | CurrentYearDuration | 25778000 | JPY |
| Gain on reversal of subscription rights to shares ope cf | CurrentYearDuration | -2000 | JPY |
| Surrender value of insurance ope cf | CurrentYearDuration | -5696000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYearDuration | -476488000 | JPY |
| Decrease increase in inventories ope cf | CurrentYearDuration | 10211000 | JPY |
| Decrease increase in prepaid expenses ope cf | CurrentYearDuration | -55387000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYearDuration | 151633000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYearDuration | -486670000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | CurrentYearDuration | 48570000 | JPY |
| Decrease increase in business guaranty money ope cf | CurrentYearDuration | 40000000 | JPY |
| Other net ope cf | CurrentYearDuration | 6937000 | JPY |
| Subtotal ope cf | CurrentYearDuration | 34549000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYearDuration | 114000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYearDuration | -1390000 | JPY |
| Income taxes paid ope cf | CurrentYearDuration | -401457000 | JPY |
| Income taxes refund ope cf | CurrentYearDuration | 1241000 | JPY |
| Net cash provided by used in operating activities | CurrentYearDuration | -366943000 | JPY |
| Proceeds from withdrawal of time deposits inv cf | CurrentYearDuration | 7201000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYearDuration | -7687000 | JPY |
| Purchase of intangible assets inv cf | CurrentYearDuration | -2775000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYearDuration | -855275000 | JPY |
| Payments for transfer of business2 inv cf | CurrentYearDuration | -85000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYearDuration | 22905000 | JPY |
| Payments of loans receivable inv cf | CurrentYearDuration | -55000000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | CurrentYearDuration | 16856000 | JPY |
| Proceeds from cancellation of insurance funds inv cf | CurrentYearDuration | 98680000 | JPY |
| Net cash provided by used in investment activities | CurrentYearDuration | -860094000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYearDuration | 200000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYearDuration | -77034000 | JPY |
| Proceeds from issuance of common stock fin cf | CurrentYearDuration | 2865321000 | JPY |
| Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cf | CurrentYearDuration | 29504000 | JPY |
| Purchase of treasury stock fin cf | CurrentYearDuration | -453194000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | 2564597000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | 1337560000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1631094000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 2968654000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 4 | |
| Accumulated depreciation ppe by group | CurrentYearInstant | -79597000 | JPY |
| Write downs of inventories | CurrentYearDuration | 11769000 | JPY |
| Advertising expenses sga | CurrentYearDuration | 2410545000 | JPY |
| Packing and freightage expenses sga | CurrentYearDuration | 480081000 | JPY |
| Depreciation sga | CurrentYearDuration | 10270000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration | 47429000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 17 of 17 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |